Will ISIS Pharmaceuticals, Inc. (ISIS) Right Pfizer Inc. (PFE)’s Wrong?
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) started the year strong with a Food and Drug Administration approval for genetic high cholesterol drug Kynamro.
Posts Tagged ‘Pfizer Inc (PFE)’
Zoetis Inc (ZTS): 3 Foolish Reasons to Buy This Expensive Stock
Make no bones about it -- Zoetis Inc (NYSE:ZTS) is one expensive stock. It even might be the most expensive health-care stock for its size.
Oncolytics Biotech, Inc. (USA) (ONCY): Huge Upside Potential Despite Recent Rallies
Shares of Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) have risen by more than 35% since last Thursday.
Is Eli Lilly & Co. (LLY) Being Wise About YZ?
It's now more than halfway through the period that Eli Lilly & Co. (NYSE:LLY) has called its "years YZ," a term describing the years spanning from 2011 to 2014.
Pfizer Inc. (PFE) and More: Should Big Pharma Follow the Spinoff Trend?
Pfizer Inc. (NYSE:PFE) faced a rough 2012 after Lipitor's loss of exclusivity in November 2011.
Does the Arthritis Market Have Growing Pains? – AbbVie Inc (ABBV)
Research firm Decision Resources predicts that the rheumatoid arthritis market will modestly grow to $15 billion in the next decade.
Better Buy: Pfizer Inc. (PFE) or Zoetis Inc (ZTS)?
Pfizer Inc. (NYSE:PFE) recently spun off animal health firm Zoetis Inc (NYSE:ZTS) in the form of an IPO.
Will Pfizer Inc. (PFE) Help You Retire Rich?
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Today’s Dow Jones Industrial Average (.DJI): Pops and Drops
It's Friday afternoon on Wall Street, and investors seem content with their holdings going into the three-day weekend.
The Dow’s Dividend Winners in 2013: 3M Co (MMM) and More
Investors look to the Dow Jones Industrials as the strongest blue-chip stocks the U.S. has to offer.
Dow Jones Industrial Average (.DJI)’s Bumpy Ride Keeps It in Positive Territory
The Dow Jones Industrial Average (INDEX:.DJI) has had a wild ride this morning, but stayed up nevertheless.
A Pipeline Worth Buying – Amgen, Inc. (AMGN)
The biotechnology industry is one of the most attractive industries for investors primarily due to its high returns.
The Next Stock You Should Consider: GlaxoSmithKline plc (ADR) (GSK)
Some of the best-performing stocks over the past several decades boast long histories of paying dividends to shareholders. Moreover, if these stocks sell for an apparent discount...
Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Rule This Multibillion-Dollar Market?
Back in 2011, generic drug giant Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) dominated the MS field, riding the coattails of its Copaxone medication to success.
Hedge Fund Kahn Brothers’ Stock Picks for 2013: The New York Times Company (NYT) and More
Hedge funds and other major investors continue to file their 13Fs for the fourth quarter of 2012 this week, disclosing many of their long equity positions as of the end of December...
Is the Pharma Industry Facing Pharmageddon? Pfizer Inc. (PFE) and More
The pharmaceuticals industry has always been one of the riskiest in the market.
The Most Trustworthy Drugs on the Market: Pfizer Inc. (PFE), Bayer AG (BAYN)
How much is trustworthiness actually worth? That somewhat strange thought entered my brain recently after reviewing the latest Harris Physician Pulse Survey.
Hedge Fund Levin Capital Strategies’ Stock Picks for 2013
This week many hedge funds and other major investors are filing their 13Fs for the fourth quarter of 2012, as these filings (which publicly disclose many of a fund’s long U....
The Dow Jones Industrial Average (.DJI) Sleepwalks Into Negative Territory: UnitedHealth Group Inc. (UNH), Pfizer Inc. (PFE)
With little news out, no major earnings on tap, and Asian markets closed for the Lunar New Year observance, investors are taking a breather today.
3 Stocks Defying the Dow’s Drop: Bank of America Corp (BAC), Pfizer Inc. (PFE) and More
Despite the lack of critical economic news today, stock markets are falling to start the week. The Dow Jones Industrial Average is down 0.15% as of 3:15 p.m.
The Best Dividend in Big Pharma: Sanofi SA (SNY), Pfizer Inc. (PFE), GlaxoSmithKline plc (GSK)
Big pharma's a good place to start if you're looking for dividend stocks.
Hedge Fund Kahn Brothers’ Stock Picks for 2013 Include Citigroup
Hedge funds and other major investors continue to file their 13Fs for the fourth quarter of 2012 this week, disclosing many of their long equity positions as of the end of December...
Dow Starts Recovering From Early-Morning Drop: Bank of America Corp (BAC), The Home Depot, Inc. (HD)
The Dow Jones Industrial Average opened flat this morning before a sharp fall, bringing it down 40 points in the first few hours of trading.
Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK): 2 Dow Stocks We All Need but Shouldn’t Own
Here at The Motley Fool, we believe the best way to invest and maximize returns is by buying strong companies and owning them for a long time.
Has Elan Corporation, plc (ADR) (ELN) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Why Depomed Inc (DEPO) Is Poised to Pull Back
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, specialty pharmaceutical company Depomed...
Dow Closes on Positive Note, But Still Down for the Week: Pfizer Inc. (PFE), The Coca-Cola Company (KO)
The Dow Jones Industrial Average ended the day up 48 points, or 0.35%, and now sits at 13,992.
Last Week’s Dow Losers: International Business Machines Corp. (IBM), Exxon Mobil Corporation (XOM)
Another wild week on Wall Street leaves investors basically were they were five days ago.
A Generic Double Whammy: Teva Pharmaceutical Industries Ltd (TEVA), Mylan Inc. (MYL)
Its narcolepsy drug Provigil saw generic competition from Par Pharmaceutical Companies, Inc. (NYSE:PRX) and Mylan Inc.
Peregrine Pharmaceuticals (PPHM): 50% Upside on this Biotechnology Stock
The patent cliff has positively impacted the valuations of small biopharmaceutical companies due to their acquisition potential.
How Far Can This Blockbuster Take Johnson & Johnson (JNJ)?
Johnson & Johnson (NYSE:JNJ) may offer well-known personal care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio of market-leading therapeutic...
Eli Lilly & Co. (LLY): If You’re Going to Fail, Fail Quickly
It's not particularly surprising given that the drug failed a phase 3 trial in December, but it's still disappointing for a company that could really use a positive result.
Investors Pull Back After Yesterday’s Rally: American Express Company (AXP), Caterpillar Inc. (CAT)
The Dow Jones Industrial Average is back in the red today, down 55 points, or 0.39%, as of 2:15 p.m. EST.
The Investor’s Guide to Zoetis Inc (ZTS): Pfizer Inc. (PFE), Merck & Co., Inc. (MRK)
Looking for the hottest name in health care? Right now it's not big pharma nor even a hot biotech firm making waves on Wall Street; it's newly minted animal health firm Zoetis...
The Impending Spinoff of a Spinoff: Covidien plc (COV), Pfizer Inc. (PFE), Abbott Laboratories (ABT)
Are you ready for another health-care spinoff? Investors experienced two already in 2013 -- and we're barely into the second month of the year.
Finding Alpha in the Healthcare Space: UnitedHealth Group Inc. (UNH), Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)
I'm a big fan of healthcare stocks. Everyone spends money on healthcare at some point in his or her life. Sometimes circumstances are unfortunate, but there is good money ...
5 Big Winners and Losers From Earnings Season: Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY)
Earnings season is a wrap for many of the brightest stars of the health care sector: Big pharma's big disappointments and successes are in the books, and investors are looking...
Teva Pharmaceutical Industries Ltd (TEVA) Earnings: An Early Look
Earnings season is in full swing, with huge numbers of companies having already given their latest numbers to investors.
Building A Better Drug Portfolio: Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), Amgen, Inc. (AMGN)
When building a drug portfolio, most investors stick to pharmaceutical firms. Since these are generally the largest, most profitable options, it's easy to see why.
Gilead Sciences, Inc. (GILD) Earnings Blaze a Star-Studded Future
The global HIV market supports a large and lucrative business environment.
3 Horrendous Health-Care Stocks This Week: Herbalife Ltd. (HLF), Celsion Corporation (CLSN) and More
It's hard to believe, but the first month of 2013 has already flown by. We ended January the same way we started it: with plenty of health-care stocks crashing.
Sex Sells: A Guide For the Socially Responsible Investor, Johnson & Johnson (JNJ), Pfizer Inc. (PFE)
Sex sells. You read this far, didn't you? Socially responsible investors are missing out on some very good companies if they maintain a prudish bent.
3 Ways to Make Money With Zoetis (Even If You Missed the IPO): Pfizer Inc. (PFE)
It's too late. If you wanted to buy into what has been hyped as the biggest IPO since Facebook Inc (NASDAQ:FB), but didn't, you missed your chance. Pfizer Inc.
How the Dogs of the Dow Did in January: Hewlett-Packard Company (HPQ), Verizon Communications Inc. (VZ) and More
Investors have never been hungrier for income, and that hunger has led to renewed interest in investing strategies that focus on maximizing income.
Two Peas in a Pharma Pod: Pfizer Inc (PFE), Bristol Myers Squibb Co. (BMY)
Pfizer's 2012 revenue was down 10%; Bristol-Myers Squibb's was off by 17%. Both are down because of expirations of megablockbusters they used to own.
$17 Billion Columbus Circle’s Stock Picks Include Apple Inc. (AAPL)
Columbus Circle Investors is an asset manager with total assets under management of $17 billion (including $1 billion in its hedge funds strategies).
Ford Motor Company (F)’s Big Debut and a Flood of Warning Signs
In the history of American markets, a few IPOs have stood out from the rest. Facebook became the largest IPO of all time in its 2012 debut.
Hedge Fund News: Steven A. Cohen, William Ackman, Telus Corporation (TU)
Hedge fund SAC Capital said yesterday it is closing down its Chicago office and laying off staff from the four portfolio teams that work there.
Billionaire Ken Fisher’s Latest Stock Picks Include Pfizer and Visa
Fisher Asset Management, which is managed by billionaire investor/author/Forbes columnist Ken Fisher, has released its 13F filing for December 2012, disclosing many of its long...
Healthcare Investor Sam Isaly’s Top Stock Picks Include Pfizer
Sam Isaly’s Orbimed Advisors is a large health care fund investing in companies at various stages from venture capital to the public markets.
